01750oam 2200469 450 991070963820332120181107143110.0(CKB)5470000002471856(OCoLC)1039079947(EXLCZ)99547000000247185620180607d2018 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierAssessing VA's risks for drug diversion hearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Fifteenth Congress, first session, Monday, February 27, 2017Washington :U.S. Government Publishing Office,2018.1 online resource (iii, 41 pages)"Serial no. 115-4."Includes bibliographical references.Assessing VA's risks for drug diversion Hospital pharmaciesSecurity measuresUnited StatesEvaluationVeterans' hospitalsSecurity measuresUnited StatesEvaluationOpioid abuseUnited StatesDrugsPrescribingCorrupt practicesUnited StatesLegislative hearings.lcgftHospital pharmaciesSecurity measuresEvaluation.Veterans' hospitalsSecurity measuresEvaluation.Opioid abuseDrugsPrescribingCorrupt practicesGPOGPOGPOMERUCOCLCFINTGPOBOOK9910709638203321Assessing VA's risks for drug diversion3471003UNINA